A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients.
Saved in:
| Title: | A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients. |
|---|---|
| Authors: | de Jonge AV; Department of Hematology, Amsterdam UMC location VU, Amsterdam, The Netherlands. a.dejonge1@amsterdamumc.nl., van Werkhoven E; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Dinmohamed AG; Department of Hematology, Amsterdam UMC location VU, Amsterdam, The Netherlands.; Erasmus MC, Department of Public Health, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Nijland M; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Zwinderman AH; Department of Clinical Epidemiology, Biostatistics, and Bioinformatics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Bossuyt PM; Department of Clinical Epidemiology, Biostatistics, and Bioinformatics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Veldhuis MS; Department of Hematology, Amsterdam UMC location VU, Amsterdam, The Netherlands., Rutten EGGM; Department of Pathology, Amsterdam UMC location VU, Amsterdam, The Netherlands., Mous R; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Sandberg Y; Department of Internal Medicine, Maasstad Hospital, Rotterdam, The Netherlands., de Jongh E; Department of Hematology, Albert Schweitzer Ziekenhuis, Dordrecht, The Netherlands., Bilgin YM; Department of Internal Medicine, Adrz, Goes, The Netherlands., Boersma R; Department of Internal Medicine, Amphia Ziekenhuis, Breda, The Netherlands., Koene H; Department of Hematology, St Antonius Ziekenhuis, Nieuwegein, The Netherlands., Kersten MJ; Department of Hematology, Amsterdam UMC location VU, Amsterdam, The Netherlands., de Jong D; Department of Pathology, Amsterdam UMC location VU, Amsterdam, The Netherlands., Chamuleau MED; Department of Hematology, Amsterdam UMC location VU, Amsterdam, The Netherlands. |
| Source: | Blood cancer journal [Blood Cancer J] 2023 May 22; Vol. 13 (1), pp. 85. Date of Electronic Publication: 2023 May 22. |
| Publication Type: | Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
